Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression

P. Costales, R. Aledo, S. Vérnia, A. Das, Vijay Shah, M. Casado, L. Badimon, V. Llorente-Cortés

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Low density lipoprotein receptor-related protein (LRP1) is upregulated in vascular smooth muscle cells by intravascular aggregated LDL (agLDL) - LDL trapped in the arterial intima and systemic LDL. LRP1 upregulation in hypercholesterolemic aortas is concomitant with SREBP downregulation. However, the specific role of SREBP isoforms in LRP1 transcription and LDL-induced LRP1 upregulation in human vascular smooth muscle cells (VSMC) is unknown. In the present study we report that specific silencing of either SREBP-1 or SREBP-2 enhanced LRP1 whereas overexpression of the active SREBP isoforms decreased LRP1 expression. Gel mobility shift and ChIP assays demonstrated that SREBP-1a, SREBP-1c and SREBP-2 were able to bind to three putative SRE sequences; SRE-A (-1042 to -1028), SRE-B (-115 to -101) and SRE-C (+226 to +234). ChIP assays demonstrated that agLDL (100 μg/mL, 24. h) significantly and specifically decreased SREBP-2 binding to the LRP1 promoter. Luciferase assays demonstrated that agLDL increased the transcriptional activity of A/B or A/C double mutants but failed to increase that of the double B/C mutant. Our results show that both SREBP-1 and SREBP-2 negatively modulated LRP1 transcription. Furthermore, agLDL exerted an upregulatory effect on LRP1 expression by decreasing SREBP-2 binding to LRP1 promoter. Two SRE-like sequences control the response of LRP1 to agLDL.

Original languageEnglish (US)
Pages (from-to)458-468
Number of pages11
JournalAtherosclerosis
Volume213
Issue number2
DOIs
StatePublished - Dec 2010

Fingerprint

Sterol Regulatory Element Binding Proteins
Low Density Lipoprotein Receptor-Related Protein-1
Blood Vessels
Protein Isoforms
Sterol Regulatory Element Binding Protein 1
Vascular Smooth Muscle
Smooth Muscle Myocytes
Up-Regulation
LDL-Receptor Related Proteins
Tunica Intima
LDL Receptors
Electrophoretic Mobility Shift Assay
oxidized low density lipoprotein
low density lipoprotein inhibitor
Luciferases
Aorta
Down-Regulation
Gels

Keywords

  • Aggregated LDL
  • Human VSMC
  • LRP1
  • SREBP-1a
  • SREBP-1c
  • SREBP-2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression. / Costales, P.; Aledo, R.; Vérnia, S.; Das, A.; Shah, Vijay; Casado, M.; Badimon, L.; Llorente-Cortés, V.

In: Atherosclerosis, Vol. 213, No. 2, 12.2010, p. 458-468.

Research output: Contribution to journalArticle

Costales, P. ; Aledo, R. ; Vérnia, S. ; Das, A. ; Shah, Vijay ; Casado, M. ; Badimon, L. ; Llorente-Cortés, V. / Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression. In: Atherosclerosis. 2010 ; Vol. 213, No. 2. pp. 458-468.
@article{24c3b18fea9043f5929bf7aedd30ff6c,
title = "Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression",
abstract = "Low density lipoprotein receptor-related protein (LRP1) is upregulated in vascular smooth muscle cells by intravascular aggregated LDL (agLDL) - LDL trapped in the arterial intima and systemic LDL. LRP1 upregulation in hypercholesterolemic aortas is concomitant with SREBP downregulation. However, the specific role of SREBP isoforms in LRP1 transcription and LDL-induced LRP1 upregulation in human vascular smooth muscle cells (VSMC) is unknown. In the present study we report that specific silencing of either SREBP-1 or SREBP-2 enhanced LRP1 whereas overexpression of the active SREBP isoforms decreased LRP1 expression. Gel mobility shift and ChIP assays demonstrated that SREBP-1a, SREBP-1c and SREBP-2 were able to bind to three putative SRE sequences; SRE-A (-1042 to -1028), SRE-B (-115 to -101) and SRE-C (+226 to +234). ChIP assays demonstrated that agLDL (100 μg/mL, 24. h) significantly and specifically decreased SREBP-2 binding to the LRP1 promoter. Luciferase assays demonstrated that agLDL increased the transcriptional activity of A/B or A/C double mutants but failed to increase that of the double B/C mutant. Our results show that both SREBP-1 and SREBP-2 negatively modulated LRP1 transcription. Furthermore, agLDL exerted an upregulatory effect on LRP1 expression by decreasing SREBP-2 binding to LRP1 promoter. Two SRE-like sequences control the response of LRP1 to agLDL.",
keywords = "Aggregated LDL, Human VSMC, LRP1, SREBP-1a, SREBP-1c, SREBP-2",
author = "P. Costales and R. Aledo and S. V{\'e}rnia and A. Das and Vijay Shah and M. Casado and L. Badimon and V. Llorente-Cort{\'e}s",
year = "2010",
month = "12",
doi = "10.1016/j.atherosclerosis.2010.09.034",
language = "English (US)",
volume = "213",
pages = "458--468",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression

AU - Costales, P.

AU - Aledo, R.

AU - Vérnia, S.

AU - Das, A.

AU - Shah, Vijay

AU - Casado, M.

AU - Badimon, L.

AU - Llorente-Cortés, V.

PY - 2010/12

Y1 - 2010/12

N2 - Low density lipoprotein receptor-related protein (LRP1) is upregulated in vascular smooth muscle cells by intravascular aggregated LDL (agLDL) - LDL trapped in the arterial intima and systemic LDL. LRP1 upregulation in hypercholesterolemic aortas is concomitant with SREBP downregulation. However, the specific role of SREBP isoforms in LRP1 transcription and LDL-induced LRP1 upregulation in human vascular smooth muscle cells (VSMC) is unknown. In the present study we report that specific silencing of either SREBP-1 or SREBP-2 enhanced LRP1 whereas overexpression of the active SREBP isoforms decreased LRP1 expression. Gel mobility shift and ChIP assays demonstrated that SREBP-1a, SREBP-1c and SREBP-2 were able to bind to three putative SRE sequences; SRE-A (-1042 to -1028), SRE-B (-115 to -101) and SRE-C (+226 to +234). ChIP assays demonstrated that agLDL (100 μg/mL, 24. h) significantly and specifically decreased SREBP-2 binding to the LRP1 promoter. Luciferase assays demonstrated that agLDL increased the transcriptional activity of A/B or A/C double mutants but failed to increase that of the double B/C mutant. Our results show that both SREBP-1 and SREBP-2 negatively modulated LRP1 transcription. Furthermore, agLDL exerted an upregulatory effect on LRP1 expression by decreasing SREBP-2 binding to LRP1 promoter. Two SRE-like sequences control the response of LRP1 to agLDL.

AB - Low density lipoprotein receptor-related protein (LRP1) is upregulated in vascular smooth muscle cells by intravascular aggregated LDL (agLDL) - LDL trapped in the arterial intima and systemic LDL. LRP1 upregulation in hypercholesterolemic aortas is concomitant with SREBP downregulation. However, the specific role of SREBP isoforms in LRP1 transcription and LDL-induced LRP1 upregulation in human vascular smooth muscle cells (VSMC) is unknown. In the present study we report that specific silencing of either SREBP-1 or SREBP-2 enhanced LRP1 whereas overexpression of the active SREBP isoforms decreased LRP1 expression. Gel mobility shift and ChIP assays demonstrated that SREBP-1a, SREBP-1c and SREBP-2 were able to bind to three putative SRE sequences; SRE-A (-1042 to -1028), SRE-B (-115 to -101) and SRE-C (+226 to +234). ChIP assays demonstrated that agLDL (100 μg/mL, 24. h) significantly and specifically decreased SREBP-2 binding to the LRP1 promoter. Luciferase assays demonstrated that agLDL increased the transcriptional activity of A/B or A/C double mutants but failed to increase that of the double B/C mutant. Our results show that both SREBP-1 and SREBP-2 negatively modulated LRP1 transcription. Furthermore, agLDL exerted an upregulatory effect on LRP1 expression by decreasing SREBP-2 binding to LRP1 promoter. Two SRE-like sequences control the response of LRP1 to agLDL.

KW - Aggregated LDL

KW - Human VSMC

KW - LRP1

KW - SREBP-1a

KW - SREBP-1c

KW - SREBP-2

UR - http://www.scopus.com/inward/record.url?scp=78649738130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649738130&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2010.09.034

DO - 10.1016/j.atherosclerosis.2010.09.034

M3 - Article

VL - 213

SP - 458

EP - 468

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -